Skip to main content
Premium Trial:

Request an Annual Quote

OmicsEdge, Almaden Genomics Partner on Clinical Trial Data Analysis Service

NEW YORK – OmicsEdge and Almaden Genomics said on Thursday that they have partnered on a service to analyze patient genomic data in clinical trials.

Under the agreement, OmicsEdge will incorporate Almaden's g.nome platform into its drug discovery service. Financial and other details were not disclosed.

"Most clinical trials do not take genomics into account as a confounding factor, even though it plays a major role in both results and analysis," Almaden Genomics CEO David Gascoigne said in a statement. "Together with OmicsEdge, our technology allows those conducting or pursuing clinical trials to incorporate genomics into the selection of targets for discovery."

Launched in 2022, g.nome offers a drag-and-drop bioinformatics workflow-building interface. Dallas-based Almaden Genomics was spun off of IBM Research in October 2022.

Miami-based OmicsEdge is part of SelfDecode, a direct-to-consumer DNA testing company, offering polygenic risk score, genetic imputation, and genome compression algorithms.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.